Salanersen

DB18418InvestigationalGene Therapies

BIIB115 is an investigational antisense oligonucleotide in development for spinal muscular atrophy.

Mechanism: Pharmacologically active on cDNA FLJ60754, moderately similar to Survival motor neuron protein
Curator reviewed
Code names: BIIB-115 · ION306

Resolves to

Compound

Targets

What you can answer from here — as of March 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Salanersen, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.